title: [Oral steroids downgraded, biologics upgraded].
authors.affiliation: .
authors.forename: Dirk
authors.initials: D
authors.lastname: Einecke
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001688:Biological Products / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D000069444:Omalizumab / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D061067:Antibodies, Monoclonal, Humanized; D001688:Biological Products; D000069444:Omalizumab; C434107:mepolizumab